Klin Farmakol Farm. 2023;37(2):72-76 | DOI: 10.36290/far.2023.013

Risks of opioid use in the elderly with persistent pain

Marek Lapka
Ústav farmakologie, 3. lékařská fakulta UK, Praha

Opioids are commonly prescribed analgesics that work by binding to opioid receptors. Although the risks associated with the opioid use have long been known, there are several issues which clinicians still encounter with. This article aims to present selected risks of long-term use of opioid analgesics in the treatment of persistent pain in the elderly and how to prevent them. Besides, it discusses the prescribing characteristics of this population with respect to their pharmacological characteristics and summarizes the specifications of selected opioid analgesics that may be considered in the elderly.

Keywords: opioids, long-term use, risks, elderly.

Accepted: July 10, 2023; Published: July 10, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lapka M. Risks of opioid use in the elderly with persistent pain. Klin Farmakol Farm. 2023;37(2):72-76. doi: 10.36290/far.2023.013.
Download citation

References

  1. Soleimanpour H, Safari S, Shahsavari Nia K, et al. Opioid Drugs in Patients With Liver Disease: A Systematic Review. Hepat Mon. 2016;16(4):e32636. doi: 10.5812/hepatmon.32636. Go to original source... Go to PubMed...
  2. Guerriero F. Guidance on opioids prescribing for the mana­gement of persistent non-cancer pain in older adults. World J Clin Cases. 2017;5(3):73-81. doi: 10.12998/wjcc.v5.i3.73. Go to original source... Go to PubMed...
  3. Rieb LM, Samaan Z, Furlan AD, et al. Canadian Guidelines on Opioid Use Disorder Among Older Adults. Can Geriatr J. 2020;23(1):123-134. doi: 10.5770/cgj.23.420. Go to original source... Go to PubMed...
  4. Qato DM, Wilder J, Schumm LP, et al. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473-482. doi: 10.1001/jamainternmed.2015.8581. Go to original source... Go to PubMed...
  5. Dufort A, Samaan Z. Problematic Opioid Use Among Older Adults: Epidemiology, Adverse Outcomes and Treatment Considerations. Drugs Aging 2021;38(12):1043-1053. Go to original source... Go to PubMed...
  6. Marcianò G, Vocca C, Evangelista M, et al. The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice. Pharmaceutics. 2023;15(4):1165. doi: 10.3390/pharmaceutics15041165. Go to original source... Go to PubMed...
  7. Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7(7):CD012592. doi: 10.1002/14651858.CD012592.pub2. Go to original source... Go to PubMed...
  8. Busse JW, Craigie S, Juurlink DN, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659-E666. doi: 10.1503/cmaj.170363. Go to original source... Go to PubMed...
  9. Dowell D, Ragan KR, Jones CM, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep. 2022;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. Go to original source... Go to PubMed...
  10. Plosker GL. Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain. Drugs. 2011;71(18):2491-509. Go to original source... Go to PubMed...
  11. Nieminen LK, Pyysalo LM, Kankaanpää MJ. Prognostic factors for pain chronicity in low back pain: a systematic review. Pain Rep. 2021;6(1):e919. doi: 10.1097/PR9.0000000000000919. Go to original source... Go to PubMed...
  12. Pergolizzi J, Varrassi G, LeQuang JAK, et al. Fixed Dose Versus Loose Dose: Analgesic Combinations. Cureus. 2023;15(1):e33320. doi: 10.7759/cureus.33320. Go to original source... Go to PubMed...
  13. Krebs EE, Gravely A, Nugent S, et al. Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA. 2018;319(9):872-882. doi: 10.1001/jama.2018.0899. Go to original source... Go to PubMed...
  14. Manchikanti L, Kaye AM, Knezevic NN, et al. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017;20(2S):S3-S92. Go to original source... Go to PubMed...
  15. Higgins C, Smith BH, Matthews K. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br J Anaesth. 2019;122(6):e114-e126. doi: 10.1016/j.bja.2018.09.019. Go to original source... Go to PubMed...
  16. Sanborn V, Gunstad J, Shrestha R, et al. Cognitive profiles in persons with opioid use disorder enrolled in methadone treatment. Appl Neuropsychol Adult. 2022;29(4):462-468. doi: 10.1080/23279095.2020.1769099. Go to original source... Go to PubMed...
  17. Prostran M, Vujović KS, Vučković S, et al. Pharmacotherapy of Pain in the Older Population: The Place of Opioids. Front Aging Neurosci. 2016;8:144. doi: 10.3389/fnagi.2016.00144. Go to original source... Go to PubMed...
  18. Tompkins DA, Huhn AS, Johnson PS, et al. To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients. Addiction. 2018;113(1):67-79. doi: 10.1111/add.13922. Go to original source... Go to PubMed...
  19. Abdulla A, Adams N, Bone M, et al; British Geriatric Society. Guidance on the management of pain in older people. Age Ageing. 2013;42 Suppl 1:i1-57. doi: 10.1093/ageing/afs200. Go to original source... Go to PubMed...
  20. Kakatkar S, Narayan A, Balkrishnan R. Prescription analgesic overuse in older adults: Can we mitigate this growing problem? Aging Med (Milton). 2022;5(4):294-296. doi: 10.1002/agm2.12228. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.